175 related articles for article (PubMed ID: 9069478)
21. Differing patterns of striatal 18F-dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Brooks DJ; Ibanez V; Sawle GV; Quinn N; Lees AJ; Mathias CJ; Bannister R; Marsden CD; Frackowiak RS
Ann Neurol; 1990 Oct; 28(4):547-55. PubMed ID: 2132742
[TBL] [Abstract][Full Text] [Related]
22. Biochemical abnormalities in basal ganglia and executive dysfunction in acute- and euthymic-episode patients with bipolar disorder: A proton magnetic resonance spectroscopy study.
Lai S; Zhong S; Liao X; Wang Y; Huang J; Zhang S; Sun Y; Zhao H; Jia Y
J Affect Disord; 2018 Jan; 225():108-116. PubMed ID: 28818755
[TBL] [Abstract][Full Text] [Related]
23. The external globus pallidus in patients with Parkinson's disease and progressive supranuclear palsy.
Hardman CD; Halliday GM
Mov Disord; 1999 Jul; 14(4):626-33. PubMed ID: 10435500
[TBL] [Abstract][Full Text] [Related]
24. Subcortical
Cho H; Choi JY; Hwang MS; Lee SH; Ryu YH; Lee MS; Lyoo CH
Mov Disord; 2017 Jan; 32(1):134-140. PubMed ID: 27813160
[TBL] [Abstract][Full Text] [Related]
25. Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy.
Clarke CE; Lowry M; Horsman A
Mov Disord; 1997 May; 12(3):297-301. PubMed ID: 9159722
[TBL] [Abstract][Full Text] [Related]
26. A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson's disease.
Firbank MJ; Harrison RM; O'Brien JT
Dement Geriatr Cogn Disord; 2002; 14(2):64-76. PubMed ID: 12145453
[TBL] [Abstract][Full Text] [Related]
27. Effect of occupational manganese exposure on the central nervous system of welders: 1H magnetic resonance spectroscopy and MRI findings.
Kim EA; Cheong HK; Choi DS; Sakong J; Ryoo JW; Park I; Kang DM
Neurotoxicology; 2007 Mar; 28(2):276-83. PubMed ID: 16824604
[TBL] [Abstract][Full Text] [Related]
28. Free-water imaging in Parkinson's disease and atypical parkinsonism.
Planetta PJ; Ofori E; Pasternak O; Burciu RG; Shukla P; DeSimone JC; Okun MS; McFarland NR; Vaillancourt DE
Brain; 2016 Feb; 139(Pt 2):495-508. PubMed ID: 26705348
[TBL] [Abstract][Full Text] [Related]
29. Brainstem proton magnetic resonance spectroscopy in idopathic REM sleep behavior disorder.
Iranzo A; Santamaria J; Pujol J; Moreno A; Deus J; Tolosa E
Sleep; 2002 Dec; 25(8):867-70. PubMed ID: 12489892
[TBL] [Abstract][Full Text] [Related]
30. Metabolic alterations in Parkinson's disease after thalamotomy, as revealed by 1H MR spectroscopy.
Baik HM; Choe BY; Lee HK; Suh TS; Son BC; Lee JM
Korean J Radiol; 2002; 3(3):180-8. PubMed ID: 12271163
[TBL] [Abstract][Full Text] [Related]
31. Metabolic changes in de novo Parkinson's disease after dopaminergic therapy: A proton magnetic resonance spectroscopy study.
Ciurleo R; Bonanno L; Di Lorenzo G; Bramanti P; Marino S
Neurosci Lett; 2015 Jul; 599():55-60. PubMed ID: 26007705
[TBL] [Abstract][Full Text] [Related]
32. Drug-induced parkinsonism in relation to choline-containing compounds measured by 1H-MR spectroscopy in putamen of chronically medicated patients with schizophrenia.
Yamasue H; Fukui T; Fukuda R; Kasai K; Iwanami A; Kato N; Kato T
Int J Neuropsychopharmacol; 2003 Dec; 6(4):353-60. PubMed ID: 14604450
[TBL] [Abstract][Full Text] [Related]
33. Striatal neuronal loss or dysfunction and choline rise in children with attention-deficit hyperactivity disorder: a 1H-magnetic resonance spectroscopy study.
Jin Z; Zang YF; Zeng YW; Zhang L; Wang YF
Neurosci Lett; 2001 Nov; 315(1-2):45-8. PubMed ID: 11711211
[TBL] [Abstract][Full Text] [Related]
34. Myoinositol and glutamate complex neurometabolite abnormality after mild traumatic brain injury.
Kierans AS; Kirov II; Gonen O; Haemer G; Nisenbaum E; Babb JS; Grossman RI; Lui YW
Neurology; 2014 Feb; 82(6):521-8. PubMed ID: 24401686
[TBL] [Abstract][Full Text] [Related]
35. Basal ganglia metabolite concentrations in idiopathic Parkinson's disease and multiple system atrophy measured by proton magnetic resonance spectroscopy.
Clarke CE; Lowry M
Eur J Neurol; 2000 Nov; 7(6):661-5. PubMed ID: 11136352
[TBL] [Abstract][Full Text] [Related]
36. [Magnetic resonance spectroscopy in Parkinson's disease and multiple system atrophy].
Aotsuka A; Shinotoh H; Hattori T
Nihon Rinsho; 1997 Jan; 55(1):249-54. PubMed ID: 9014459
[TBL] [Abstract][Full Text] [Related]
37. Glutamate measurement in Parkinson's disease using MRS at 3 T field strength.
Kickler N; Krack P; Fraix V; Lebas JF; Lamalle L; Durif F; Krainik A; Rémy C; Segebarth C; Pollak P
NMR Biomed; 2007 Dec; 20(8):757-62. PubMed ID: 17334978
[TBL] [Abstract][Full Text] [Related]
38. The internal globus pallidus is affected in progressive supranuclear palsy and Parkinson's disease.
Hardman CD; Halliday GM
Exp Neurol; 1999 Jul; 158(1):135-42. PubMed ID: 10448425
[TBL] [Abstract][Full Text] [Related]
39. Proton magnetic resonance spectroscopy of basal ganglia in chronic schizophrenia.
Fujimoto T; Nakano T; Takano T; Takeuchi K; Yamada K; Fukuzako T; Akimoto H
Biol Psychiatry; 1996 Jul; 40(1):14-8. PubMed ID: 8780850
[TBL] [Abstract][Full Text] [Related]
40. 1H-MRS experiences after bilateral DBS of the STN in Parkinson's disease.
Llumiguano C; Kovacs N; Usprung Z; Schwarcz A; Dóczi TP; Balas I
Parkinsonism Relat Disord; 2008; 14(3):229-32. PubMed ID: 17913561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]